Buschmann, T., Potapova, O., Bar-Shira, A., Ivanov, V. N., Fuchs, S. Y., Henderson, S., Fried, V. A., Minamoto, T., Alarcon-Vargas, D., Pincus, M. R., el al. (2001). Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol Cell Biol 21, 2743-2754.

Chehab, N. H., Malikzay, A., Appel, M., and Halazonetis, T. D. (2000). Chk2/hCdsl functions as a DNA damage checkpoint in G(l) by stabilizing p53. Genes Dev 14, 278-288. Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D„ Schuler, M., and Green, D. R. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014. Chowdary, D. R., Dermody, J. J., Jha, K. K., and Ozer, H. L. (1994). Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Biol 14, 1997-2003. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C„ Hooper, M. L„ and Wyllie, A. H. (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852.

Crook, T., Marston, N. J., Sara, E. A., and Vousden, K. H. (1994). Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79, 817-827. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G„ el al. (2002). Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4, 11-19.

Damalas, A., Ben-Ze'ev, A., Simcha, I., Shtutman, M., Leal, J. F., Zhurinsky, J., Geiger, B., and Oren, M. (1999). Excess beta-catenin promotes accumulation of transcriptionally active p53. Embo J 18, 3054-3063.

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221. Dornan, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G. D., Dowd, P., K, O. R„ Koeppen, H„ and Dixit, V. M. (2004). The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature.

Erster, S., Mihara, M., Kim, R. H., Petrenko, O., and Moll, U. M. (2004). In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24, 6728-6741. Espinosa, J. M., and Emerson, B. M. (2001). Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 8, 57-69. Everett, R. D., Meredith, M„ and Orr, A. (1999). The ability of herpes simplex virus type 1 immediate-early protein VmwllO to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication. J Virol 73, 417-426.

Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F., and Jacks, T. (2002). p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416, 560-564.

Fotedar, R., Bendjennat, M., and Fotedar, A. (2004). Role of p21 WAF1 in the cellular response to UV. Cell Cycle 3, 134-137. Freedman, D. A., Wu, L., and Levine, A. J. (1999). Functions of the MDM2 oncoprotein. Cell Mol Life Sci 55, 96-107. Fridman, J. S., and Lowe, S. W. (2003). Control of apoptosis by p53. Oncogene 22, 9030-9040.

Friedlander, P., Haupt, Y., Prives, C., and Oren, M. (1996). A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol 16, 4961-4971. Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., and Ronai, Z. (1998). JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev 12, 2658-2663. Girnita, L., Girnita, A., and Larsson, O. (2003). Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci USA 100, 8247-8252. Goodman, R. H., and Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev 14, 1553-1577. Gray, W. M., Hellmann, H., Dharmasiri, S., and Estelle, M. (2002). Role of the Arabidopsis RING-H2 protein RBX1 in RUB modification and SCF function. Plant Cell 14, 2137-2144. Gu, J., Kawai, H., Nie, L., Kitao, H., Wiederschain, D., Jochemsen, A. G., Parant, J., Lozano, G., and Yuan, Z. M. (2002). Mutual dependence of MDM2 and MDMX in their functional inactivation ofp53. J Biol Chem 277, 19251-19254. Gu, W., and Roeder, R. G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.

Gu, W„ Shi, X. L„ and Roeder, R. G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-823. Guarente, L. (2000). Sir2 links chromatin silencing, metabolism, and aging. Genes Dev 14, 1021-1026.

Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. (1994). Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54, 2095-2097.

Haupt, S„ Berger, M„ Goldberg, Z„ and Haupt, Y. (2003). Apoptosis - the p53 network. J Cell Sci 116, 4077-4085. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299. Hirao, A., Kong, Y. Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H„ Liu, D., Elledge, S. J., and Mak, T. W. (2000). DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827.

Hoffman, W. H„ Biade, S., Zilfou, J. T., Chen, J., and Murphy, M. (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277, 3247-3257. Hofmann, T. G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y„ Droge, W., Will, H., and Schmitz, M. L. (2002). Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4, 1-10.

Holowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J., and Frappier, L. (2003). Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J Biol Chem 278, 29987-29994. Honda, R., Tanaka, H., and Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420, 25-27.

Honda, R., and Yasuda, H. (1999). Association of pl9(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. Embo J 18, 22-27.

Horn, H. F., and Vousden, K. H. (2004). Cancer: guarding the guardian? Nature 427, 110-111.

Hsieh, J. K., Chan, F. S., O'Connor, D. J., Mittnacht, S„ Zhong,

S., and Lu, X. (1999). RB regulates the stability and the apoptotic function ofp53 via MDM2. Mol Cell 3, 181-193.

Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. (1992).

Regulation of the specific DNA binding function of p53. Cell 71,

0 0

Post a comment